| $350M | ||
| $172M | ||
| $115M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $21,261 | 9 | 41 |
Sells | $531,758 | 13 | 59 |
| chiang yao-chung | director | 9 | $21,261 | 0 | $0 | $21,261 |
| TSAI CHUN-JUNG | director | 0 | $0 | 2 | $53,510 | $-53,510 |
| lee ting-chuan | director | 0 | $0 | 3 | $237,621 | $-237,621 |
| Taiwan Carbon Nano Technology Corp | 10 percent owner | 0 | $0 | 8 | $240,627 | $-240,627 |
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Over the last 12 months, insiders at Ainos, Inc. have bought $21,261 and sold $531,758 worth of Ainos, Inc. stock.
On average, over the past 5 years, insiders at Ainos, Inc. have bought $402,142 and sold $327,072 worth of stock each year.
Highest buying activity among insiders over the last 12 months: chiang yao-chung (director) — $21,261.
The last purchase of 3,500 shares for transaction amount of $7,175 was made by chiang yao-chung (director) on 2026‑06‑05.
| 2026-06-05 | chiang yao-chung | director | 3,500 0.0813% | $2.05 | $7,175 | -21.03% | ||
| 2026-06-03 | chiang yao-chung | director | 2,000 0.0428% | $2.13 | $4,260 | -29.09% | ||
| 2026-05-28 | chiang yao-chung | director | 250 0.0046% | $2.30 | $575 | -42.34% | ||
| 2026-05-27 | chiang yao-chung | director | 2,000 0.0345% | $2.00 | $4,000 | -38.09% | ||
| 2026-05-26 | Sale | Taiwan Carbon Nano Technology Corp | 10 percent owner | 41,000 0.8348% | $2.36 | $96,760 | -49.68% | |
| 2026-05-26 | Sale | lee ting-chuan | director | 109,988 1.8029% | $1.90 | $208,977 | -49.68% | |
| 2026-05-26 | Sale | TSAI CHUN-JUNG | director | 27,718 0.4472% | $1.87 | $51,833 | -49.68% | |
| 2026-05-22 | Sale | lee ting-chuan | director | 9,302 0.2108% | $1.57 | $14,604 | +4.25% | |
| 2026-05-22 | Sale | TSAI CHUN-JUNG | director | 1,082 0.0242% | $1.55 | $1,677 | +4.25% | |
| 2026-05-21 | Sale | lee ting-chuan | director | 9,000 0.1963% | $1.56 | $14,040 | +0.63% | |
| 2026-05-19 | chiang yao-chung | director | 2,200 0.0527% | $1.68 | $3,696 | +1.94% | ||
| 2026-05-18 | chiang yao-chung | director | 500 0.011% | $1.65 | $825 | -4.82% | ||
| 2026-05-05 | chiang yao-chung | director | 129 0.003% | $1.70 | $219 | -4.05% | ||
| 2026-04-30 | chiang yao-chung | director | 200 0.0046% | $1.68 | $336 | -2.87% | ||
| 2026-04-29 | chiang yao-chung | director | 100 0.0024% | $1.75 | $175 | -1.16% | ||
| 2026-01-28 | Sale | Taiwan Carbon Nano Technology Corp | 10 percent owner | 46,000 1.2177% | $2.17 | $99,806 | -23.71% | |
| 2026-01-09 | Sale | Taiwan Carbon Nano Technology Corp | 10 percent owner | 431 0.009% | $1.86 | $802 | -11.29% | |
| 2026-01-08 | Sale | Taiwan Carbon Nano Technology Corp | 10 percent owner | 850 0.0178% | $1.80 | $1,534 | -7.82% | |
| 2025-10-06 | Sale | Taiwan Carbon Nano Technology Corp | 10 percent owner | 7,000 0.14% | $3.59 | $25,130 | -53.63% | |
| 2025-10-02 | Sale | Taiwan Carbon Nano Technology Corp | 10 percent owner | 2,000 0.0445% | $3.58 | $7,170 | -50.00% |
| Taiwan Carbon Nano Technology Corp | 10 percent owner | 948925 12.8851% | $1.37M | 0 | 13 | |
| lee ting-chuan | director | 807417 10.9636% | $1.16M | 1 | 4 | |
| TSAI CHUN-JUNG | director | 658199 8.9374% | $947,806.56 | 1 | 7 | |
| chiang yao-chung | director | 11279 0.1532% | $16,241.76 | 10 | 0 | |
| AINOS INC | 10 percent owner | 12926082 175.5178% | $18.61M | 0 | 1 | |
| Paul Tibbits | 9417696 127.8789% | $13.56M | 40 | 0 | ||
| chang wen-han | director | 4000000 54.3143% | $5.76M | 1 | 0 | |
| MUELLER PETER ROBERT | COO & DIRECTOR OF RESEARCH | 1163186 15.7944% | $1.67M | 3 | 1 | |
| CHEN STEPHEN T | President,Chairman,CEO,CFO | 783000 10.632% | $1.13M | 351 | 3 | |
| CUMMINS JOSEPH M | PRES,CEO,CHAIRMAN OF THE BOARD | 781724 10.6147% | $1.13M | 7 | 47 | |
| THOMAS R ULIE | director | 771300 10.4732% | $1.11M | 1 | 0 | |
| COY GARY WAYNE | 581354 7.894% | $837,149.76 | 10 | 1 | ||
| tsai chun-hsien | CHIEF EXECUTIVE OFFICER | 333986 4.5351% | $480,939.84 | 1 | 0 | |
| Cummins Martin Joseph | VP,CLINICAL & REGULATORY AFFAI | 135966 1.8462% | $195,791.04 | 2 | 1 | |
| ASE Test, Inc. | 10 percent owner | 58887 0.7996% | $84,797.28 | 1 | 0 | <0.0001% |
| Cohen Bernard H | Vice President & CFO | 58836 0.7989% | $84,723.84 | 1 | 0 | |
| D'ALONZO THOMAS W | director | 28672 0.3893% | $41,287.68 | 2 | 0 | |
| MOORE DENNIS DEAN | director | 10000 0.1358% | $14,400.00 | 3 | 2 | |
| PAGE JAMES A | director | 0 0% | $0 | 1 | 2 |
$18,815,063 | 62 | -6.45% | $12.73M | |
$931,435 | 28 | 16.31% | $10.24M | |
$29,645,465 | 28 | 8.09% | $9.58M | |
$76,600 | 22 | -37.70% | $11.97M | |
$37,200,153 | 21 | -47.67% | $7.59M | |
$287,718 | 15 | -41.45% | $8.6M | |
$684,058 | 11 | -57.59% | $13.63M | |
$120,379 | 10 | -24.48% | $11.74M | |
$13,595,542 | 9 | -16.74% | $8.92M | |
$8,731,108 | 7 | 153.66% | $10.73M | |
$56,660 | 7 | -68.80% | $12.93M | |
$159,974 | 7 | -18.60% | $11.36M | |
$5,117,729 | 6 | -52.29% | $12.97M | |
$18,186,879 | 4 | 49.41% | $10.52M | |
$84,550 | 3 | 77.61% | $14.44M | |
$28,395 | 3 | 3.48% | $10.26M | |
$16,526,031 | 2 | -0.85% | $8.96M | |
Ainos, Inc. (AIMD) | $295 | 1 | -14.11% | $10.6M |
$500,000 | 1 | -22.94% | $10.58M |
| Increased Positions | 9 | +150% | 116,997 | +88.59% |
| Decreased Positions | <1 | -16.67% | 522 | -0.4% |
| New Positions | 2 | New | 32,996 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 14 | +133.33% | 248,546 | +88.19% |
| Renaissance Technologies Llc | $103.00 | 0.84% | 58,600 | +58,600 | New | 2025-09-30 |
| Vanguard Group Inc | $43.00 | 0.35% | 24,750 | +24,750 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $40.00 | 0.33% | 23,008 | +23,008 | New | 2025-09-30 |
| Drw Securities, Llc | $31.00 | 0.25% | 17,772 | +17,772 | New | 2025-09-30 |
| Blackrock, Inc. | $5.00 | 0.04% | 3,065 | 0 | 0% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $3.00 | 0.03% | 1,810 | +754 | +71.4% | 2025-09-30 |
| Seneschal Advisors, Llc | $3.00 | 0.03% | 1,800 | +1,800 | New | 2025-09-30 |
| Steward Partners Investment Advisory, Llc | $2.00 | 0.02% | 1,208 | 0 | 0% | 2025-09-30 |
| Citigroup Inc | $0 | <0.01% | 38 | +38 | New | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | 0% | 17 | +9 | +112.5% | 2025-09-30 |